Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SEH1L |
| Upstream (Parents) |
|---|
| (<<) CCNB1 → SEH1L |
| (<<) CCNB2 → SEH1L |
| (<<) CD3EAP → SEH1L |
| (<<) CIRH1A → SEH1L |
| (<<) CTPS → SEH1L |
| (<<) DHX9 → SEH1L |
| (<<) DLAT → SEH1L |
| (<<) ENO1 → SEH1L |
| (<<) GAPDH → SEH1L |
| (<<) IGFBP4 → SEH1L |
| (<<) KLF2 → SEH1L |
| (<<) ME1 → SEH1L |
| (<<) PIK3R2 → SEH1L |
| (<<) PLK1 → SEH1L |
| (<<) PRKX → SEH1L |
| (<<) PTK2 → SEH1L |
| (<<) PTPMT1 → SEH1L |
| (<<) RRAS2 → SEH1L |
| (<<) SFXN4 → SEH1L |
| (<<) TK2 → SEH1L |
| (<<) TMSB10 → SEH1L |
| (<<) UBE2C → SEH1L |
| (<<) YRDC → SEH1L |
| Downstream (Children) |
|---|
| SEH1L → ASB1 (>>) |
| SEH1L → BBS1 (>>) |
| SEH1L → CFL2 (>>) |
| SEH1L → CXCL14 (>>) |
| SEH1L → DNM1L (>>) |
| SEH1L → GAL (>>) |
| SEH1L → HSP90AA1 (>>) |
| SEH1L → KHDRBS1 (>>) |
| SEH1L → LRP8 (>>) |
| SEH1L → MAP3K12 (>>) |
| SEH1L → MEF2D (>>) |
| SEH1L → MIA3 (>>) |
| SEH1L → MYO1E (>>) |
| SEH1L → NCOR2 (>>) |
| SEH1L → NFATC4 (>>) |
| SEH1L → NRAS (>>) |
| SEH1L → PFDN2 (>>) |
| SEH1L → PNO1 (>>) |
| SEH1L → POP1 (>>) |
| SEH1L → SHC2 (>>) |
| SEH1L → SOD2 (>>) |
| SEH1L → TAF1A (>>) |
| SEH1L → TM4SF1 (>>) |
| SEH1L → UBE2I (>>) |
| SEH1L → UBQLN1 (>>) |
